Taiwan Mangoes Head to Europe as Premium Fruit Exports Expand 
Stripe, Advent Offer $53 Billion Deal to Acquire PayPal: Reuters 
Stellantis Q2 Vehicle Shipments Rise 10% as North America Drives Growth 
ASML Raises 2026 Outlook as AI Chip Demand Lifts Q2 Earnings 
SK Hynix Stock Soars as AI Memory Demand Outlook Fuels Chip Rally 
Genesis Minerals to Acquire Vault in A$5.6 Billion Deal After Regis Withdraws 
Arm Stock Falls After HSBC Downgrade, Citing Limited Near-Term AI Upside 
Apple Intelligence Cleared for China as Alibaba and Baidu AI Power iPhone Features 
Jamie Dimon Warns Anthropic's Mythos AI Poses National Security Risks 
BHP Faces Major Port Hedland Strike as Labor Talks Stall Ahead of Production Report 
SpaceX Stock Falls Below IPO Price as Investors Weigh Losses and Lockup Expiry 
DBS Targets S$1 Trillion Wealth AUM by 2030 Amid Asia Wealth Boom 
BHP Q4 Iron Ore Output Rebounds as Copper Prices Boost Revenue 
Rio Tinto Reports Strong Q2 Iron Ore Sales, Maintains 2026 Production Outlook 
UBS Boosts China Tech Bets, Adds Kuaishou and Meituan to Focus List 
United Airlines Beats Q2 Earnings, Raises 2026 Profit Outlook Despite Higher Fuel Costs 
xAI Sues Man for Allegedly Using Grok to Generate AI Child Abuse Deepfakes 
PETALUMA, Calif., Jan. 21, 2016 -- Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) (tradable warrants OCLSW) today announced that the financial results for its fiscal third quarter 2016, ended December 31, 2015, will be released after the U.S. markets close on February 4, 2016. The earnings release will be followed by a conference call at 1:30 p.m. PT on February 4, 2016, to discuss fiscal third quarter results.
Individuals interested in participating in the conference call may do so by dialing 877-303-7607 for domestic callers or 973-638-3203 for international callers. Those interested in listening to the conference call live via the internet may do so at http://ir.oculusis.com/events.cfm. Please log on approximately 30 minutes prior to the presentation in order to register and download the appropriate software.
A telephone replay will be available for seven days following the conclusion of the call by dialing 855-859-2056 for domestic callers, or 404-537-3406 for international callers, and entering conference code 28872996. A webcast replay will be available on the site at http://ir.oculusis.com/events.cfm for one year following the call.
About Oculus Innovative Sciences, Inc.
Oculus Innovative Sciences is a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and advanced tissue care. The company’s products, which are sold throughout the United States and internationally, have improved outcomes for more than five million patients globally by reducing infections, itch, pain, scarring and harmful inflammatory responses. The company's headquarters are in Petaluma, California, with manufacturing operations in the United States and Latin America. European marketing and sales are headquartered in Roermond, Netherlands. More information can be found at www.oculusis.com.
Media and Investor Contact:
Oculus Innovative Sciences, Inc.
Dan McFadden
VP of Public and Investor Relations
(425) 753-2105
[email protected]
